Jul 7, 2026 08:03AM
Jul 7, 2026 08:00AM
Jun 2, 2026 08:04AM
Jun 2, 2026 08:00AM
Apr 28, 2026 08:00AM
Apr 8, 2026 08:01AM
Apr 8, 2026 08:00AM Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
Mar 26, 2026 08:00AM
Mar 17, 2026 08:00AM
Mar 10, 2026 08:00AM
Mar 9, 2026 08:00AM
Mar 3, 2026 08:32AM
Mar 3, 2026 08:32AM
Mar 3, 2026 08:30AM Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
Mar 3, 2026 08:00AM
Feb 24, 2026 08:06AM
Feb 24, 2026 08:00AM
Feb 10, 2026 08:04AM
Feb 10, 2026 08:00AM
Nov 25, 2025 08:00AM
Oct 21, 2025 08:00AM Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
Oct 15, 2025 08:00AM
Oct 15, 2025 08:00AM
Sep 30, 2025 08:00AM
Sep 23, 2025 08:04AM
Sep 23, 2025 08:00AM
Sep 4, 2025 08:00AM
Sep 4, 2025 08:00AM Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care
Sep 3, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 12, 2025 08:00AM
Aug 7, 2025 07:58AM
Aug 7, 2025 07:55AM
Jul 22, 2025 08:00AM
May 14, 2025 08:00AM Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
May 13, 2025 08:00AM
May 13, 2025 08:00AM
May 7, 2025 08:00AM
May 6, 2025 08:00AM
May 6, 2025 08:00AM
Apr 22, 2025 08:00AM
Apr 17, 2025 08:00AM Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
Apr 15, 2025 08:00AM
Apr 10, 2025 08:02AM
Apr 10, 2025 08:00AM
Apr 2, 2025 08:02AM
Apr 2, 2025 08:00AM
Mar 28, 2025 08:00AM
Mar 4, 2025 04:55PM Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024
Mar 4, 2025 03:53PM

325,466 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All